HeartSciences annual operating margin
2022
2023
2024
2025
HeartSciences's operating margin was −192,013.13% for fiscal 2025.
View full HeartSciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-04-30 | −192,013.13% | −158111.14 pp |
| 2024 | 2024-04-30 | −33,901.99% | +84796.34 pp |
| 2023 | 2023-04-30 | −118,698.33% | −85932.73 pp |
| 2022 | 2022-04-30 | −32,765.60% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2025-10-31 | −85,713.23% | −18569.49 pp |
| Q1 2026 | 2025-07-31 | −98,637.84% | −53947.31 pp |
| Q3 2024 | 2024-01-31 | −10,376.75% | +37292.81 pp |
| Q2 2024 | 2023-10-31 | −40,254.95% | −98.49 pp |
| Q3 2023 | 2023-01-31 | −67,143.74% | −58131.91 pp |
| Q1 2023 | 2022-07-31 | −44,690.53% | — |
| Q4 2022 | 2022-04-30 | −47,669.56% | — |
| Q3 2022 | 2022-01-31 | −40,156.46% | — |
| Q1 2022 | 2021-07-31 | −9,011.84% | — |
Across the available reported history, HeartSciences's operating margin decreased from −33,901.99% to −192,013.13%, a change of −158111.14 percentage points. The latest reported quarter, Q2 2026, shows −85,713.23%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences filings at SEC.gov ↗